Published in Toxins (Basel) on August 01, 2010
Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease. Toxins (Basel) (2010) 1.26
Shiga toxin pathogenesis: kidney complications and renal failure. Curr Top Microbiol Immunol (2012) 0.86
Role of Shiga/Vero toxins in pathogenesis. Microbiol Spectr (2014) 0.79
Shiga Toxin Mediated Neurologic Changes in Murine Model of Disease. Front Cell Infect Microbiol (2016) 0.75
The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis (1985) 16.43
The hemolytic-uremic syndrome. Nephron (1973) 3.34
Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem Int (2004) 3.16
Haemolytic-uraemic syndrome: clinical experience of an outbreak in the West Midlands. Br Med J (Clin Res Ed) (1986) 2.47
The importance of nonrenal involvement in hemolytic-uremic syndrome. Pediatrics (1980) 1.89
CNS manifestations of the hemolytic-uremic syndrome. Relationship to metabolic alterations and prognosis. Am J Dis Child (1980) 1.87
Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome. J Pediatr (1994) 1.72
Risk factors for the central nervous system manifestations of gastroenteritis-associated hemolytic-uremic syndrome. Pediatrics (1992) 1.71
Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins. J Biol Chem (2006) 1.44
Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2. Infect Immun (1996) 1.30
The circumventricular organs: an atlas of comparative anatomy and vascularization. Brain Res Rev (2007) 1.28
Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide. Proc Natl Acad Sci U S A (1990) 1.27
Enterohemorrhagic Escherichia coli (EHEC) in pediatric hemolytic-uremic syndrome: a prospective study in Germany and Austria. Infection (2000) 1.25
Neurological manifestations of hemorrhagic colitis in the outbreak of Escherichia coli O157:H7 infection in Japan. Acta Paediatr (1993) 1.17
Lessons learned in the management of hemolytic uremic syndrome in children. J Pediatr Surg (1995) 1.17
Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons. J Infect Dis (2008) 1.16
CT and MRI in haemolytic uraemic syndrome with central nervous system involvement: distribution of lesions and prognostic value of imaging findings. Pediatr Radiol (2004) 1.12
The hemolytic-uremic syndrome. West J Med (1981) 0.95
Immunohistologic techniques for detecting the glycolipid Gb(3) in the mouse kidney and nervous system. Histochem Cell Biol (2008) 0.92
Central nervous system involvement in a child with hemolytic uremic syndrome. Pediatr Nephrol (2000) 0.88
Clinical and pathologic aspects of central nervous system involvement in the haemolytic uraemic syndrome. Proc Aust Assoc Neurol (1971) 0.82
Hemolytic uremic syndrome: MR findings of CNS complications. Pediatr Radiol (1994) 0.81
Hemolytic uremic syndrome associated with Corynebacterium diphtheria infection. Int J Pediatr Nephrol (1986) 0.78
Lacunar infarction of the basal ganglia as a complication of hemolytic-uremic syndrome. MRI and clinical correlations. Clin Pediatr (Phila) (1987) 0.78
Mechanism of Clostridium difficile toxin A-induced apoptosis in T84 cells. J Infect Dis (2002) 1.32
Rapid apoptosis induced by Shiga toxin in HeLa cells. Infect Immun (2003) 1.23
Caspase and bid involvement in Clostridium difficile toxin A-induced apoptosis and modulation of toxin A effects by glutamine and alanyl-glutamine in vivo and in vitro. Infect Immun (2006) 1.18
ZAK: a MAP3Kinase that transduces Shiga toxin- and ricin-induced proinflammatory cytokine expression. Cell Microbiol (2008) 1.16
Alanyl-glutamine hastens morphologic recovery from 5-fluorouracil-induced mucositis in mice. Nutrition (2004) 1.04
An A2A adenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis models. BMC Infect Dis (2008) 1.02
Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function. Infect Immun (2005) 0.96
Shiga toxin 2 causes apoptosis in human brain microvascular endothelial cells via C/EBP homologous protein. Infect Immun (2008) 0.94
Shiga toxin 2 and lipopolysaccharide cause monocytic THP-1 cells to release factors which activate platelet function. Thromb Haemost (2005) 0.85
Protection by a recombinant Mycobacterium bovis Bacillus Calmette-Guerin vaccine expressing Shiga toxin 2 B subunit against Shiga toxin-producing Escherichia coli in mice. Clin Vaccine Immunol (2012) 0.81